Search - tctmd.com

Displaying 981 - 1000 of 4255

Sort: Relevancy | Date

Presentation TCT 2015

Evaluation of Initial Surgical Versus Conservative Strategies in Patients With Asymptomatic Severe Aortic Stenosis

Presenter: Tomohiko Taniguchi

October 15, 2015

Presentation TCT 2015

BRAVO 3: A Prospective Randomized Trial of Bivalirudin Versus Heparin in Patients Undergoing Transcatheter Aortic Valve Replacement

Presenter: Thierry Lefevre

October 15, 2015

Presentation TCT 2015

SAPIEN 3: Evaluation of a Balloon-Expandable Transcatheter Aortic Valve in High-Risk and Inoperable Patients With Aortic Stenosis – One-Year Outcomes

Presenter: Howard C. Herrmann

October 15, 2015

News Conference News TCT 2015

Valve-in-Valve TAVR Benefits Patients with Failing Surgical Bioprosthetic Valves

Todd Neale

October 15, 2015

News Industry News

Study Shows Initial Aortic Valve Replacement In Asymptomatic Patients With Severe Aortic Stenosis May be Viable Treatment Option

October 15, 2015

News Industry News

Similar Results With Bivalirudin Compared With Heparin Anticoagulation In TAVR Patients

October 15, 2015

News Conference News TCT 2015

Low 1-Year Event Rates Seen After TAVR With Sapien 3

Todd Neale

October 15, 2015

News Conference News TCT 2015

Initial Surgical AVR Improves Long-term Outcomes in Asymptomatic Patients With Severe AS

October 15, 2015

News Industry News

Favorable Results At One Year With Newest Generation Of Balloon-Expandable Transcatheter Aortic Valve In High-Risk And Inoperable Patients With Aortic Stenosis

October 15, 2015

News Industry News

Edwards SAPIEN XT Valve Receives FDA Approval For Aortic Valve-In-Valve Procedures

October 15, 2015

News Industry News

Edwards SAPIEN 3 Valve Demonstrates High Survival And Low Stroke Rate At 1 Year

October 15, 2015

News Conference News TCT 2015

BRAVO 3: Bivalirudin Similar to Heparin in Transfemoral TAVR

Yael L. Maxwell

October 15, 2015

Presentation TCT 2015

Novel Sheath Technology for TAVR

Presenter: Susheel Kodali, Axel Linke, Hemal Gada

October 14, 2015

Presentation TCT 2015

Dedicated Guidewires for TAVR

Presenter: Susheel Kodali, Axel Linke, Wesley R. Pedersen

October 14, 2015

Presentation TCT 2015

An Update of New Aortic Valvuloplasty and Valve Remodeling Technologies

Presenter: Susheel Kodali, Axel Linke, Martin B. Leon

October 14, 2015

Presentation TCT 2015

Cerebral Embolic Protection Devices: Triguard Deflector Device Technology Review and DEFLECT III Results

Presenter: Susheel Kodali, Axel Linke, Alexandra J. Lansky

October 14, 2015

Presentation TCT 2015

The State of the Art of Transcatheter Treatment of Aortic Coarctation in Adults

Presenter: Ziyad M. Hijazi, Robert J. Sommer, John P. Cheatham

October 14, 2015

Presentation TCT 2015

Cerebral Embolic Protection Devices: Sentinel Dual Filter Device Update of US Pivotal Clinical Trial

Presenter: Susheel Kodali, Axel Linke

October 14, 2015

Presentation TCT 2015

Cerebral Embolic Protection Devices: Sentinel Dual Filter Device Technology Review and CLEAN-TAVI Results

Presenter: Susheel Kodali, Axel Linke

October 14, 2015

Presentation TCT 2015

Early Stage New TAVR Systems: Venus A Valve Technology Review and Clinical Update

Presenter: Martin B. Leon, Nicolo Piazza, Horst Sievert

October 14, 2015

Advertisement

Evaluation of Initial Surgical Versus Conservative Strategies in Patients With Asymptomatic Severe Aortic Stenosis

BRAVO 3: A Prospective Randomized Trial of Bivalirudin Versus Heparin in Patients Undergoing Transcatheter Aortic Valve Replacement

SAPIEN 3: Evaluation of a Balloon-Expandable Transcatheter Aortic Valve in High-Risk and Inoperable Patients With Aortic Stenosis – One-Year Outcomes

Valve-in-Valve TAVR Benefits Patients with Failing Surgical Bioprosthetic Valves

Study Shows Initial Aortic Valve Replacement In Asymptomatic Patients With Severe Aortic Stenosis May be Viable Treatment Option

Similar Results With Bivalirudin Compared With Heparin Anticoagulation In TAVR Patients

Low 1-Year Event Rates Seen After TAVR With Sapien 3

Initial Surgical AVR Improves Long-term Outcomes in Asymptomatic Patients With Severe AS

Favorable Results At One Year With Newest Generation Of Balloon-Expandable Transcatheter Aortic Valve In High-Risk And Inoperable Patients With Aortic Stenosis

Edwards SAPIEN XT Valve Receives FDA Approval For Aortic Valve-In-Valve Procedures

Edwards SAPIEN 3 Valve Demonstrates High Survival And Low Stroke Rate At 1 Year

BRAVO 3: Bivalirudin Similar to Heparin in Transfemoral TAVR

Novel Sheath Technology for TAVR

Dedicated Guidewires for TAVR

An Update of New Aortic Valvuloplasty and Valve Remodeling Technologies

Cerebral Embolic Protection Devices: Triguard Deflector Device Technology Review and DEFLECT III Results

The State of the Art of Transcatheter Treatment of Aortic Coarctation in Adults

Cerebral Embolic Protection Devices: Sentinel Dual Filter Device Update of US Pivotal Clinical Trial

Cerebral Embolic Protection Devices: Sentinel Dual Filter Device Technology Review and CLEAN-TAVI Results

Early Stage New TAVR Systems: Venus A Valve Technology Review and Clinical Update

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content